Cancer-specific ligands identified from screening of peptide-display libraries.
about
Multifunctional polymeric micelles for delivery of drugs and siRNA.Selection of phage-displayed peptides on live adherent cells in microfluidic channels.Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines.Peptide aptamers: recent developments for cancer therapy.Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis.Panning and identification of a colon tumor binding peptide from a phage display peptide library.Trinucleotide cassettes increase diversity of T7 phage-displayed peptide library.Liposomes targeted by fusion phage proteinsIdentification of cyclic peptides able to mimic the functional epitope of IgG1-Fc for human Fc gammaRI.Potential of phage-displayed peptide library technology to identify functional targeting peptidesPaclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity.Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein.Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy.Phage display and molecular imaging: expanding fields of vision in living subjects.Landscape phages and their fusion proteins targeted to breast cancer cells.On the mechanism of targeting of phage fusion protein-modified nanocarriers: only the binding peptide sequence mattersPeptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.Advancement and applications of peptide phage display technology in biomedical sciencePeptide-mediated targeting of liposomes to TrkB receptor-expressing cells.Cancer treatment using peptides: current therapies and future prospectsNonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs.Advances in molecular imaging of pancreatic beta cellsEnhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein.HPMA-copolymer conjugates targeted to tumor endothelium using synthetic oligopeptides.Bifunctional phage-based pretargeted imaging of human prostate carcinoma.Optimization of Landscape Phage Fusion Protein-Modified Polymeric PEG-PE Micelles for Improved Breast Cancer Cell Targeting.Identification of a Novel Tumor-Binding Peptide for Lung Cancer Through in-vitro Panning.Immunocompatibility of Bacteriophages as Nanomedicines
P2860
Q30438973-CB14DCA9-4A30-4248-909E-7503A9C38EADQ31004986-191870DB-B71B-4B1C-9412-709ACC04C763Q31163147-5167E94C-5993-4B58-B4F2-E6D8394B6FB4Q33216999-76549E00-292A-46FA-9AD9-CB9A13E57ED5Q33225648-223FE28F-2A08-4087-ACA0-06E3D08DAC3EQ33276355-96CEEF8A-9034-44F8-AE43-BAB6D26B5316Q33301751-12A5C5C6-5514-4677-991E-64A1D9AB0524Q33374206-9671B746-D92B-4697-8FF4-CDAB675AC37FQ33380014-60D17B34-A6D0-4C0A-B3A8-0091EDAC4933Q33530848-9C85168A-BA16-4E59-A76A-1C3804BA1C51Q33592506-17804B0B-6986-4A7E-8FA3-5BB92483C5DBQ33596415-4189ED55-48F6-45C2-80C2-3F34374E4F5BQ33771285-4E0E4487-BF5C-4EE9-91F1-4F46FF811CE6Q33829569-F2BCF591-C60C-40EC-8F39-E7CA76DB5DDCQ33849788-DF8E7C3F-B2CF-4463-8ED4-B1CEEE63EF5DQ34227310-C0D37A61-FF84-40FC-9276-969D6212509FQ35256650-560A4B13-B302-4821-9D80-F1D204E1F8CFQ35783096-F402467D-F8C6-421E-A4B5-DA4F54320A26Q35898339-13F9608A-FAAC-40CE-8383-803DF0E22309Q36119579-1E1A0EF8-963F-4795-A42D-BC567F569310Q36515785-9130B833-42B1-4B49-AEAF-6000A0101DB1Q36752048-5A5D7E2F-76E2-4FAC-A9FE-3D8778BBD485Q37183977-88A38F56-99CE-4EF5-87FA-991204AA10A7Q37466693-5189A05E-D800-4A0F-9842-9414900E29B0Q37624040-3BFF0EA3-8441-45DC-86B3-8B6AC9922ED6Q39782523-6F0BBCDC-598A-49C6-B2EE-1991C70E7CB0Q39805831-48002979-383B-44CD-A238-A28EF361730FQ41257114-61BDBE51-34BA-4073-A298-0027D4B313BBQ54969380-7DADAEA0-EFC5-4703-99D5-AF758C4B1EC8Q58910820-D9627891-94FA-4375-A67F-94ADBBF51D4E
P2860
Cancer-specific ligands identified from screening of peptide-display libraries.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cancer-specific ligands identified from screening of peptide-display libraries.
@ast
Cancer-specific ligands identified from screening of peptide-display libraries.
@en
type
label
Cancer-specific ligands identified from screening of peptide-display libraries.
@ast
Cancer-specific ligands identified from screening of peptide-display libraries.
@en
prefLabel
Cancer-specific ligands identified from screening of peptide-display libraries.
@ast
Cancer-specific ligands identified from screening of peptide-display libraries.
@en
P356
P1476
Cancer-specific ligands identified from screening of peptide-display libraries.
@en
P2093
P304
P356
10.2174/1381612043383944
P577
2004-01-01T00:00:00Z